Evolent Health Announces Changes to Board of Directors

Core Viewpoint - Evolent Health, Inc. is enhancing its Board of Directors as part of its commitment to strong corporate governance and collaboration with shareholders, with Rick Jelinek set to become Chair and Brendan Springstubb appointed as a new independent director [1][2][3]. Board Changes - Rick Jelinek will be named Chair of the Board at the 2025 Annual Meeting, succeeding Cheryl Scott, who has served since 2022 [2][5]. - Brendan Springstubb joins the Board as an independent director, bringing over 20 years of experience in investing in healthcare companies and expertise in strategy and investor communications [3][6]. Board Refreshment Efforts - The Board plans to refresh an independent director seat before the 2025 Annual Meeting, continuing a search process overseen by the Nominating and Governance Committee [4]. - Evolent has added five new independent directors to its Board in the past three years, reflecting ongoing efforts to enhance governance [4]. Leadership Insights - Cheryl Scott emphasized that the rotation of the Chair role and continued Board refreshment align with best practices in corporate governance [5]. - Glenn W. Welling, a significant shareholder, expressed confidence in Springstubb's ability to advocate for shareholders and highlighted Evolent's strong competitive position [5]. - CEO Seth Blackley noted the importance of the Board's skills and experience in creating value for stakeholders [5].